Salarius Pharmaceuticals, Inc. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Salarius Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -110 %, a 48% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Return On Assets for 2023 was -135 %, a 10.7% decline from 2022.
  • Salarius Pharmaceuticals, Inc. annual Return On Assets for 2022 was -122 %, a 338% decline from 2021.
  • Salarius Pharmaceuticals, Inc. annual Return On Assets for 2021 was -27.9 %, a 17.9% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -135 -13.1 -10.7% Jan 1, 2023 Dec 31, 2023
2022 -122 -94.3 -338% Jan 1, 2022 Dec 31, 2022
2021 -27.9 +6.08 +17.9% Jan 1, 2021 Dec 31, 2021
2020 -34 +29.6 +46.6% Jan 1, 2020 Dec 31, 2020
2019 -63.5 -53.1 -507% Jan 1, 2019 Dec 31, 2019
2018 -10.5 +65.5 +86.2% Jan 1, 2018 Dec 31, 2018
2017 -76 -23.1 -43.6% Jan 1, 2017 Dec 31, 2017
2016 -52.9 -24.8 -88.3% Jan 1, 2016 Dec 31, 2016
2015 -28.1 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.